There are 1 item(s) in your cart
Requires Prescription
CannazoIndia Cannaronil Syringe, Balanced Raw CBD:THC (1:1), 5000mg, 5 gm
Vijaya Extract Balanced Raw CBD:THC (1:1), 5000mg, 5 gm
₹4,499.00
Product by:
Cannazo India
Description
Vijaya Extract is a thick paste made from the extracts of the cannabis plant. It is extremely potent and effective in action. To balance such high potency, it is enriched with a mixture of cannabinoids, terpenes and flavonoids facilitating an entourage effect.(The ratio is an estimate as per overall results seen till now, which can differ from batch to batch.)
Brand CannazoIndiaCannazoIndia is creating products focused on natural healing using ancient Ayurvedic and homeopathic knowledge. Using the power of ‘ Vijaya’ Cannazo aims to develop a range of multi-purpose products to improve the health and wellness of the users. Cannazo is tracing its way back to the roots of shlokas and Vedas of Ayurveda to help India be self-reliant for remedies.Founded: 2021
Shipping Countries: India
Ready to ship in 1-2 business days from India
Reviews
Write a Review
- Requires Prescription
CannazoIndia Women Wellness, 1000mg, 15ml
₹999.00Women Wellness is an Ayurvedic formulation that combines the therapeutic attributes of 6 powerful herbs mentioned in the ancient texts.… - Requires Prescription
CannazoIndia Painaid External care, 3000mg, 15ml
₹2,999.00For chronic pain external application. PainAID External Care is an Ayurvedic formulation that contains a powerful mixture of Vijaya leaf… - Requires Prescription
CannazoIndia Painaid External care, 6000mg, 30ml
₹5,999.00For chronic pain external application. PainAID External Care is an Ayurvedic formulation that contains a powerful mixture of Vijaya leaf… - Requires Prescription
CannazoIndia Cannaronil Syringe, CBD Rich (4:1), 5000mg, 5 gm
₹4,999.00Vijaya Extract CBD Rich (4:1), 5000mg, 5 gm - Requires Prescription
CannazoIndia Vijaya Amrit CBD Oil (4:1), 2000mg, 15ml
₹3,999.00CannazoIndia Vijaya Amrit CBD Oil (4:1), 2000mg, 15ml
Reviews
There are no reviews yet.